Therapeutic and routine prophylactic properties of rFactor VIII Fc (efraloctocog alfa, Eloctate®) in hemophilia A

Therapeutic and routine prophylactic properties of rFactor VIII Fc (efraloctocog alfa, Eloctate®) in hemophilia A

Pratima Chowdary,1 Emma Fosbury,1 Anne Riddell,1 Mary Mathias1,2 1Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free Hospital, London, UK; 2Haemophilia Centre, Great Ormond Street Hospital for Children, London, UK Abstract: rFVIIIFc (efraloctocog alfa, Eloctate®) is an ex...

Full description

Bibliographic Details
Main Authors: Chowdary P, Fosbury E, Riddell A, Mathias M
Format: Article
Language:English
Published: Dove Medical Press 2016-09-01
Series:Journal of Blood Medicine
Subjects:
Haemophilia A
rFVIII Fc
Prophylaxis
FVIII
extended half-life factors
efraloctocog alfa
Online Access:https://www.dovepress.com/therapeutic-and-routine-prophylactic-properties-of-rfactor-viii-fc-efr-peer-reviewed-article-JBM

Internet

https://www.dovepress.com/therapeutic-and-routine-prophylactic-properties-of-rfactor-viii-fc-efr-peer-reviewed-article-JBM

Similar Items